Dr. Mark Pimentel
Table of Contents
What Is ibs-smart™ and How Does It Diagnose IBS?
How Food Poisoning Leads to IBS
Biomarker and Blood Test Validation
Clinical Applications of
ibs-smart™ for Gastroenterologists
Clinical Applications of ibs-smart for Primary Care Physicians
Selecting Patients and Patient Counseling
Understanding the Test Results
Recommendations for Patients With Positive Test Results
IBS and SIBO
Mark Pimentel, MD, is Professor of Medicine at Geffen School of Medicine and Cedars-Sinai Medical Center in Los Angeles, California.
Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS and the relationship between gut flora composition and human disease.
A few of Dr. Pimentel’s most significant accomplishments include:
Discovered rifaximin as a treatment for irritable bowel syndrome (IBS).
Developed the first blood test for IBS on the basis of IBS being derived from acute gastroenteritis.
Described the association between IBS and bacterial overgrowth which forms the basis for microbiome therapies in this condition.
Uncovered the methanogen (Methanobrevibacter smithii) as an agent for causing constipation in humans.
Discovered the use of lovastatin as a microbiome treatment for constipation on the basis of inhibiting methane production by methanogens.